FDA ISSUES RECOMMENDATIONS TO REDUCE THE RISK OF ZIKA VIRUS TRANSMISSION BY HUMAN CELL AND TISSUE PRODUCTS
As an additional safety measure against the emerging Zika virus outbreak, the U.S. Food and Drug Administration issued new guidance for immediate implementation providing recommendations to reduce the potential transmission risk of Zika virus from human cells, tissues, and cellular and tissue-based products (HCT/Ps).